| Literature DB >> 32364426 |
Julia E Heck1,2, Pei-Chen Lee3, Chia-Kai Wu3, Chung-Yi Li4,5,6, Di He1, Noah Federman7, Fei Yu8, Jorn Olsen1,9, Beate Ritz1, Onyebuchi A Arah1, Johnni Hansen10.
Abstract
Spina bifida has been reported to co-occur with pediatric cancer, but comprehensive evaluations remained elusive. We investigated this co-occurrence in two large, population-based studies in Taiwan (N = 1900 cancer cases, 2,077,137 controls) and Denmark (N = 5508 cases, 137,700 controls). Analyses in Denmark were restricted to the period before prenatal diagnostics became available (2004) and pregnancy terminations of fetuses with birth defects became more common. Using national patient and cancer registries, we linked spina bifida and cancer diagnoses among cases and non-cases. The risk of spina bifida among all cancer cases was increased and similar in Denmark [odds ratio (OR)=8.4, 95% confidence interval (CI) 5.1-13.8] and Taiwan (OR = 8.5, 95% CI 4.0-17.8), particularly for central nervous system (CNS) tumors (Denmark: OR = 16.3, 95% CI 8.1-33.0; Taiwan: OR = 26.6, 95% CI 8.5, 83.1), including benign CNS tumors (Denmark: OR = 41.5, 95% CI 21.2, 81.4). These findings suggest the need for comprehensive investigation of shared risk factors in the link between spina bifida and pediatric cancer.Entities:
Keywords: Birth defects; central nervous system tumors; childhood cancer epidemiology; folate; spina bifida
Year: 2020 PMID: 32364426 PMCID: PMC7577564 DOI: 10.1080/08880018.2020.1760409
Source DB: PubMed Journal: Pediatr Hematol Oncol ISSN: 0888-0018 Impact factor: 1.969